We are excited to share that Altiscreen has been selected for Venture Kick’s first stage of financial and entrepreneurial support, securing CHF 10,000 to accelerate the development of our rapid on-site drug detection device.

Venture Kick is one of Switzerland’s leading startup support initiatives, helping early-stage companies transform innovative ideas into scalable businesses. Alongside Altiscreen, four other promising ventures were selected, covering fields such as AI filmmaking, smart mobility for the visually impaired, reusable e-commerce packaging, and fetal-maternal monitoring.

For Altiscreen, this achievement represents an important validation of our mission: to address the growing need for fast, portable, and accurate drug detection solutions. Unlike conventional bulky or slow testing systems, our device delivers results in just minutes, detecting up to nine substances simultaneously across sample types such as oral fluid and urine.

The funding from Venture Kick will enable us to move forward with the first commercial production batch, strengthen business development activities, and accelerate our market entry. This milestone marks another step toward reducing healthcare costs, preventing workplace accidents, and supporting law enforcement and healthcare professionals in their daily work.

We are proud to stand alongside other innovative startups in this cohort and grateful to Venture Kick for their trust and support.